FindTrial
Sign In

THE ROLE OF GENETICS IN HEART ATTACK.

GENETIC STUDY OF PERILIPIN[PLIN]1 GENE MUTATIONS IN ACUTE CORONARY SYNDROME - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/063909
Enrollment
84
Registered
2024-03-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I229- Subsequent ST elevation (STEMI) myocardial infarction of unspecified site

Interventions

Intervention1: NIL.: NIL.

Sponsors

BLDE DEEMED TO BE UNIVERSITY SHRIBMPATIL MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE
Lead Sponsor
DRANKUSH PRAMOD DARGOPATIL
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS ADMITTED WITH ACUTE CORONARY SYNDROME.

Exclusion criteria

Exclusion criteria: PATIENTS WITH VALVULAR HEART DISEASE PATIENTS WITH PULMONARY EMBOLISM PATENTIS WITH CONGENITAL HEART DISEASE

Design outcomes

Primary

MeasureTime frame
TO IDENTIFY THE INDIVIDUAL RISK OF PERILIPIN[PLIN]1 GENE MUTATIONS IN ACUTE CORONARY SYNDROME.Timepoint: 12 MONTHS—

Secondary

MeasureTime frame
THE SECONDARY OUTCOME OF THE STUDY WILL BE IMPLIED BY IDENTIFYING POPULATION AT RISK AND IN PROVIDING COMPREHENSIVE CARE AND TREATMENT BY EARLY SCREENING WHICH CAN REDUCE MORTALITY AND MORBIDITY DUE TO ACUTE CORONARY SYNDROMETimepoint: 12 MONTHS—

Countries

India

Contacts

Public ContactDR.BADIGER SHARANABASAWAPPA

B.L.D.E. (DEEMED TO BE UNIVERSITY)

sharanrb@rediffmail.com09448434927

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026